Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Dompé’s Oxervate gets approval to treat neurotrophic keratitis in US

pharmaceuticalAugust 27, 2018

Tag: neurotrophic keratitis , Dompé’s Oxervate

PharmaSources Customer Service